Pharmacists are advised to exercise caution when dispensing Memantine 10mg Film-Coated Tablets by Crescent Pharma

The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a class 4 pharmacy level caution in use for Memantine 10mg Film-Coated Tablets.

Crescent Pharma Ltd has informed the government agency of a discrepancy on the product packaging for three batches. The discrepancy relates to the incorrect quantity printed on one side (end flap) of the packs in error.

“The incorrect end flap states that the quantity of tablets within the pack is 30, however, this is incorrect and should state 28 as per all other sides of the pack. The other product details on the pack including the name, strength and pharmaceutical form of the medicine are correct,” an official statement read.

Pharmacists are advised to exercise caution when dispensing the product. There is no risk to product quality as a result of this issue, therefore the associated batches are not being recalled at this time.

Product details:

Batch Number Expiry Date Pack Size
10819 08/2022 28
20819 08/2022 28
11119 11/2022 28

If you want to share your stories and/or experiences with us, please send an email to [email protected]

LEAVE A REPLY